Evidence map›Paper›PMID 21748754›Full record

ArticleThe Prostate2012

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.

Lingyi Lu, Geraldine Cancel-Tassin, Antoine Valeri, Olivier Cussenot, Ethan M Lange, Kathleen A Cooney, James M Farnham, Nicola J Camp, Lisa A Cannon-Albright, Teuvo L J Tammela and 49 more

Registry-linked trialOpen access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in The Prostate, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01221168 (ProGene), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01221168 recruitingnot on this map

ProGene: Etude Genetique et Epidemiologique du Cancer de la Prostate Familial

TypeobservationalSponsorCentre de Recherche sur les Pathologies ProstatiquesRan1996 to 2026Enrolled10,000ConditionsProstate Cancer
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Association of a NovelIranian journal of public health · 2021
    Article
  2. Article
  3. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors at 20 institutions in 9 countries.

Lingyi LuData Coordinating Center for the ICPCG and Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Geraldine Cancel-Tassin
Antoine Valeri
Olivier Cussenot
Ethan M Lange
Kathleen A Cooney
James M Farnham
Nicola J Camp
Lisa A Cannon-Albright
Teuvo L J Tammela
Johanna Schleutker
Josef Hoegel
Kathleen Herkommer
Christiane Maier
Walther Vogel
Fredrik Wiklund
Monica Emanuelsson
Henrik Grönberg
Kathleen E Wiley
Sarah D Isaacs
Patrick C Walsh
Brian T Helfand
Donghui Kan
William J Catalona
Janet L Stanford
Liesel M FitzGerald
Bo Johanneson
Kerry Deutsch
Laura McIntosh
Elaine A Ostrander
Stephen N Thibodeau
Shannon K McDonnell
Scott Hebbring
Daniel J Schaid
Alice S Whittemore
Ingrid Oakley-Girvan
Chih-Lin Hsieh
Isaac Powell
Joan E Bailey-Wilson
Cheryl D Cropp
Claire Simpson
John D Carpten
Daniela Seminara
S Lilly Zheng
Jianfen Xu
Graham G Giles
Gianluca Severi
John L Hopper
Dallas R English
William D Foulkes
Lovise Maehle
Pal Moller
Michael D Badzioch
Steve Edwards
Michelle Guy
Ros Eeles
Douglas Easton
William B Isaacs
International Consortium for Prostate Cancer Genetics
Johns Hopkins University · USMayo Clinic · USUniversität Ulm · DEFred Hutch Cancer Center · USKarolinska Institutet · SENorthwestern University · USUniversity of Utah · USWake Forest University · USCancer Council Victoria · AUHôpital Tenon · FRNorwegian Cancer Society · NORoyal Marsden NHS Foundation Trust · GBStanford Medicine · USTampere University · FITampere University Hospital · FIUniversity of Melbourne · AUCancer Research UK · GBInstitute for Systems Biology · USInstitute of Cancer Research · GBMcGill University · CA

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
TRANSGENIC MODELS FOR PROSTATE CANCER AND AUTOIMMUNITYP50CA058236 · NCI · JOHNS HOPKINS UNIVERSITY · PI DENMEADE, SAMUEL R · 1992 to 2020
$43.9M
Prostate Cancer Susceptibility: The ICPCG StudyU01CA089600 · NCI · MAYO CLINIC ROCHESTER · PI THIBODEAU, STEPHEN NORMAN · 2002 to 2016
$27.3M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
UNIVERSITY OF UTAH MEDICAL INFORMATICS TRAININGT15LM007124 · NLM · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Karen Louise Eilbeck · 1997 to 2026
$22.0M
Finding Genes for Human Prostate CancerZIAHG200325 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI OSTRANDER, ELAINE · 2009 to 2021
$17.7M
Genetic Epidemiology of CancerZIAHG200331 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$11.7M
GENETIC EPIDEMIOLOGY OF PROSTATE CANCERR01CA080122 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STANFORD, JANET L · 1999 to 2008
$3.8M
GENETICS OF PROSTATE CANCER SUSCEPTIBILITYR01CA078836 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, PETER S · 1999 to 2005
$3.3M
GENETIC ANALYSIS OF HEREDITARY PROSTATE CANCER FAMILIESR01CA079596 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COONEY, KATHLEEN A · 1999 to 2009
$3.0M
Mapping and Cloning Prostate Cancer Predisposition LociR01CA090752 · NCI · UNIVERSITY OF UTAH · PI ALBRIGHT, LISA CANNON · 2001 to 2004
$2.3M
Cancer Research UK 10118Cancer Research UK 10588Cancer Research UK 11022Cancer Research UK 15007Cancer Research UK C5047/A3354Intramural NIH HHSNCI NIH HHS CA079596NCI NIH HHS CA106523NCI NIH HHS CA58236NCI NIH HHS CA67044NCI NIH HHS CA72818NCI NIH HHS CA78836NCI NIH HHS CA80122NCI NIH HHS CA90752NCI NIH HHS CA95052NCI NIH HHS CA98364NCI NIH HHS K07 CA098364NCI NIH HHS N01 PC035141NCI NIH HHS N01-PC-35141NCI NIH HHS P30 CA015704NCI NIH HHS P30 CA042014NCI NIH HHS P50 CA058236NCI NIH HHS R01 CA067044NCI NIH HHS R01 CA072818NCI NIH HHS R01 CA078836NCI NIH HHS R01 CA079596NCI NIH HHS R01 CA080122NCI NIH HHS R01 CA090752NCI NIH HHS R01 CA095052NCI NIH HHS R01 CA106523NCI NIH HHS U01 CA067044NCI NIH HHS U01 CA089600NCI NIH HHS U01 CA89600NCRR NIH HHS UL1 RR025741NLM NIH HHS T15 LM007124
6 · The paper itself

Abstract

backgroundIn spite of intensive efforts, understanding of the genetic aspects of familial prostate cancer (PC) remains largely incomplete. In a previous microsatellite-based linkage scan of 1,233 PC families, we identified suggestive evidence for linkage (i.e., LOD ≥ 1.86) at 5q12, 15q11, 17q21, 22q12, and two loci on 8p, with additional regions implicated in subsets of families defined by age at diagnosis, disease aggressiveness, or number of affected members.

methodsIn an attempt to replicate these findings and increase linkage resolution, we used the Illumina 6000 SNP linkage panel to perform a genome-wide linkage scan of an independent set of 762 multiplex PC families, collected by 11 International Consortium for Prostate Cancer Genetics (ICPCG) groups.

resultsOf the regions identified previously, modest evidence of replication was observed only on the short arm of chromosome 8, where HLOD scores of 1.63 and 3.60 were observed in the complete set of families and families with young average age at diagnosis, respectively. The most significant linkage signals found in the complete set of families were observed across a broad, 37 cM interval on 4q13-25, with LOD scores ranging from 2.02 to 2.62, increasing to 4.50 in families with older average age at diagnosis. In families with multiple cases presenting with more aggressive disease, LOD scores over 3.0 were observed at 8q24 in the vicinity of previously identified common PC risk variants, as well as MYC, an important gene in PC biology.

conclusionsThese results will be useful in prioritizing future susceptibility gene discovery efforts in this common cancer.

Indexed as

Genome-Wide Association StudyInternational CooperationAgedChromosomes, Human, Pair 4Chromosomes, Human, Pair 8Data Interpretation, StatisticalGenetic LinkageGenetic Predisposition to DiseaseGenotypeHumansLod ScoreMalePedigreePolymorphism, Single NucleotideProstatic Neoplasms

Identifiers

PMID21748754
PMCPMC3568777
OpenAlexW2164440220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.